Ilker Atay
Dokuz Eylul, 35210, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Hyperkalemia Risk After Finerenone Initiation in Diabetic Kidney Disease with Elevated Baseline Potassium: A Multicenter Cohort Study.
Journal: Journal of clinical medicine
Published: June 16, 2026
Early laboratory trajectories and short-term tolerability after finerenone initiationin diabetic kidney disease: the multicenter FINE-TURK study.
Journal: BMC nephrology
Published: May 09, 2026
Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.
Journal: Clinical kidney journal
Published: April 01, 2026
Obinutuzumab for membranous nephropathy: a systematic review using pooled case-level extraction analysis.
Journal: Acta clinica Belgica
Published: March 19, 2026
Clinicopathologic characteristics and long-term outcomes in glomerulonephritis with crescent formation: a 20-year single-center cohort study.
Journal: Acta clinica Belgica
Published: February 18, 2026
Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy.
Journal: Kidney international reports
Published: December 23, 2025
Associations between serum electrolyte impairments and frailty status in older adults.
Journal: International urology and nephrology
Published: August 31, 2025
Predictors of kidney disease progression after renal artery stenting.
Journal: BMC nephrology
Published: January 11, 2025
Showing 1-8 of 8
Last Updated: 09/26/2026